Cancer Biomarkers in Diagnosis and Therapeutics (Record no. 29349)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02029nam a22002297a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 20241028104107.0 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20241028104403.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 241028b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-981-16-5758-0 |
| International Standard Book Number | 978-981-16-5759-7 (eBook) |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | ddc |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Fuller form of name | Adeeb Shehzad |
| 245 ## - TITLE STATEMENT | |
| Title | Cancer Biomarkers in Diagnosis and Therapeutics |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Department of Biomedical Engineering and Sciences, School of Mechanical and Manufacturing Engineering (SMME) National University of Sciences and Technology Islamabad, Pakistan | |
| Name of publisher, distributor, etc. | Springer Nature Singapore Pte Ltd | |
| Date of publication, distribution, etc. | 2022 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 372 Pages |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | This book illustrates the basics and underlying molecular machinery of cancer cells and biochemical assays that detect the type and stage of cancer through cell signaling biomarkers. It starts with a brief introduction to cancer biomarkers and addresses technologies for identifying and validating cancer biomarkers, biomarkers for cancer drug development, prognostic and diagnostic biomarkers, and microbiome as cancer biomarkers. It reviews predictive biomarkers for anticancer drugs, biomarkers in cancer survival and drug resistance, biomarkers in tumor recurrence and metastasis, the role of the biomarker in immunotherapy and personalized medicine, and the development of a novel cancer biomarker. Finally, this book also underpins the role of nanotechnology in the use and detection of cancer biomarkers for enhanced sensitivity and specificity. Lastly, it discusses the challenges with biomarkers in cancer drug discovery and development. This volume is an indispensable tool for researchers working in the field of cancer and also for clinical oncologists. |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| General subdivision | Cancer, Cancer-Treatment, Medical / General, Medical / Oncology / General, Nanomedicine, Tumor markers, Biochemical markers -- Diagnostic use, Cancer -- Diagnosis. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href=" https://doi.org/10.1007/978-981-16-5759-7 "> https://doi.org/10.1007/978-981-16-5759-7 </a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Suppress in OPAC | |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total checkouts | Barcode | Date last seen | Uniform resource identifier | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 10/28/2024 | 20241028104107.0 | 10/28/2024 | https://doi.org/10.1007/978-981-16-5759-7 | 10/28/2024 | E-BOOKS |